Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer

NCT00702182 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Vinorelbine (Navelbine)
DRUG: Vinorelbine (Navelbine)
DRUG: Erlotinib

Sponsor

National Cancer Centre, Singapore